Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.35B | 1.04B | 1.14B | 1.56B | 1.66B | 1.05B | Gross Profit |
320.35M | 243.30M | 238.30M | 269.40M | 292.50M | 178.30M | EBIT |
63.25M | 36.20M | 12.50M | -32.30M | 29.70M | -3.80M | EBITDA |
117.55M | 65.00M | 44.50M | 23.70M | 51.10M | 26.90M | Net Income Common Stockholders |
34.15M | 24.70M | -2.60M | -30.40M | 17.70M | 1.70M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
40.10M | 40.10M | 19.10M | 19.50M | 67.10M | 6.90M | Total Assets |
441.80M | 441.80M | 460.30M | 549.20M | 615.70M | 449.00M | Total Debt |
70.90M | 70.90M | 95.30M | 153.60M | 95.30M | 106.00M | Net Debt |
30.80M | 30.80M | 76.20M | 134.10M | 28.20M | 99.10M | Total Liabilities |
304.00M | 304.00M | 354.60M | 476.80M | 519.30M | 369.30M | Stockholders Equity |
137.80M | 137.80M | 105.70M | 73.40M | 97.70M | 80.70M |
Cash Flow | Free Cash Flow | ||||
75.00M | 53.30M | 22.20M | -62.00M | 105.50M | 6.10M | Operating Cash Flow |
84.35M | 61.60M | 24.40M | -52.40M | 114.60M | 14.10M | Investing Cash Flow |
-11.55M | -7.60M | 7.70M | -9.60M | -9.10M | -7.90M | Financing Cash Flow |
-43.25M | -33.00M | -32.30M | 14.40M | -45.30M | -28.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | £1.01B | 5.05 | 2.95% | ― | -10.46% | 396.13% | |
69 Neutral | £1.36B | 20.68 | 20.52% | 3.18% | 6.97% | -14.59% | |
66 Neutral | £565.03M | 21.02 | 20.28% | ― | -0.39% | 2.68% | |
65 Neutral | £6.75B | 13.23 | 17.19% | 0.90% | 6.87% | 22.36% | |
60 Neutral | £5.49B | 40.14 | 2.25% | 5.51% | 2.66% | 80.49% | |
59 Neutral | $12.37B | 11.05 | 1.62% | 3.72% | 1.33% | -19.92% |